|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 282.14 USD | +1.43% |
|
-5.82% | -0.87% |
| Jan. 13 | Insulet Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 11:15 AM | |
| Jan. 12 | Insulet Shares Fall After Barclays Downgrade | MT |
| Capitalization | 19.57B 16.79B 15.63B 14.55B 27.15B 1,767B 29.27B 180B 70.71B 845B 73.39B 71.88B 3,096B | P/E ratio 2025 * |
79.8x | P/E ratio 2026 * | 45.2x |
|---|---|---|---|---|---|
| Enterprise value | 19.79B 16.99B 15.82B 14.72B 27.46B 1,787B 29.61B 182B 71.53B 855B 74.24B 72.71B 3,132B | EV / Sales 2025 * |
7.35x | EV / Sales 2026 * | 5.98x |
| Free-Float |
99.46% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Insulet Corporation
| 1 day | +1.70% | ||
| 1 week | -5.60% | ||
| Current month | -0.64% | ||
| 1 month | -3.12% | ||
| 3 months | -11.27% | ||
| 6 months | -3.29% | ||
| Current year | -0.64% |
| 1 week | 275.1 |  | 297.37 |
| 1 month | 275.1 | | 299.8 |
| Current year | 275.1 | | 299.8 |
| 1 year | 230.05 | | 354.88 |
| 3 years | 125.82 | | 354.88 |
| 5 years | 125.82 | | 354.88 |
| 10 years | 23.94 | | 354.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ashley McEvoy
CEO | Chief Executive Officer | 55 | 2025-04-27 |
Flavia Pease
DFI | Director of Finance/CFO | 53 | 2025-09-29 |
Laetitia Cousin
CMP | Compliance Officer | 50 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Timothy Scannell
CHM | Chairman | 61 | 2018-12-31 |
Jessica Hopfield
BRD | Director/Board Member | 61 | 2015-07-26 |
Michael Minogue
BRD | Director/Board Member | 59 | 2017-08-09 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -5.60% | +5.76% | -5.52% | 19.57B | |
| -0.02% | -2.36% | +9.75% | +9.40% | 216B | |
| +1.89% | -1.65% | +15.10% | +22.12% | 124B | |
| +0.72% | +2.33% | +45.11% | +112.19% | 67.1B | |
| +2.45% | +1.68% | -12.59% | -19.49% | 57.41B | |
| +4.93% | +7.07% | +27.36% | +96.63% | 52.63B | |
| +0.67% | +6.11% | - | - | 35.66B | |
| -2.06% | -1.38% | -12.68% | -36.87% | 27.4B | |
| +1.06% | +1.27% | +26.46% | +31.32% | 25.51B | |
| -2.33% | -5.96% | +3.81% | -35.10% | 24.31B | |
| Average | +0.89% | -0.67% | +12.01% | +19.41% | 64.93B | |
| Weighted average by Cap. | +0.99% | -1.48% | +13.45% | +24.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.69B 2.31B 2.15B 2B 3.73B 243B 4.03B 24.72B 9.73B 116B 10.09B 9.89B 426B | 3.25B 2.78B 2.59B 2.41B 4.5B 293B 4.85B 29.81B 11.73B 140B 12.17B 11.92B 514B |
| Net income | 250M 214M 199M 186M 346M 22.54B 373M 2.29B 902M 10.78B 936M 917M 39.51B | 435M 373M 347M 323M 603M 39.25B 650M 3.99B 1.57B 18.78B 1.63B 1.6B 68.8B |
| Net Debt | 227M 194M 181M 168M 314M 20.45B 339M 2.08B 819M 9.78B 850M 832M 35.85B | -174M -149M -139M -129M -241M -15.7B -260M -1.6B -628M -7.51B -652M -639M -27.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-14 | 282.68 $ | +1.62% | 453,494 |
| 26-01-13 | 278.17 $ | -0.14% | 667,396 |
| 26-01-12 | 278.55 $ | -3.63% | 622,874 |
| 26-01-09 | 289.04 $ | -1.31% | 901,965 |
| 26-01-08 | 292.89 $ | -2.10% | 653,453 |
Delayed Quote Nasdaq, January 14, 2026 at 02:07 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PODD Stock
Select your edition
All financial news and data tailored to specific country editions
